Entering text into the input field will update the search result below
Join now
Search for Symbols, analysts, keywords
Log in
ESRX
Express Scripts, Inc.
Stock Price & Overview
Follow
ESRX is defunct since January 1, 2019.
Summary
All
Analysis
Comments
News
Transcripts
SEC Filings
Press Releases
Related Analysis
Analysis
See All Analysis »
News
Latest Headlines
All
Articles
News
ElectroCore inks rebate agreement with Ascent Health Services; shares up 6% premarket
U.S. healthcare spending to rise 5.5% per annum over next decade
Maryland strikes out in reviving drug price-gouging law
Humana not on board with Trump's proposed drug rebate program
Drug wholesalers/PBMs claw back from selloff from proposed elimination of rebates
Hospitals squeezed by high drug costs
FDA to beef up cell and gene therapy staff
FDA Commish touts advances/successes
Rep. Cummings opens investigation into drug prices
Dem lawmakers introduce bill to lower U.S. drug prices
More News And Analysis »
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.